Diphtheria Tetanus and Pertussis Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Overall Market Size
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size: 2022 VS 2030
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market
3.2 Top Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies Ranked by Revenue
3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Companies
3.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Companies
3.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Markets, 2022 & 2030
4.1.2 Immune DTaP Vaccine
4.1.3 Therapy DTaP Vaccine
4.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
4.3.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2023
4.3.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2024-2030
4.3.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2022 & 2030
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
5.3.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2023
5.3.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2024-2030
5.3.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
6.3.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2023
6.3.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2024-2030
6.3.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2030
6.4.3 US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.4.4 Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.4.5 Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2030
6.5.3 Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5.4 France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5.5 U.K. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5.6 Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5.7 Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.5.9 Benelux Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2030
6.6.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.6.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.6.5 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.6.7 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2030
6.7.3 Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.7.4 Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2018-2030
6.8.3 Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.8.4 Israel Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
6.8.6 UAE Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Company Summary
7.3.2 Protein Sciences Corporation Business Overview
7.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Protein Sciences Corporation Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Seqirus
7.5.1 Seqirus Company Summary
7.5.2 Seqirus Business Overview
7.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Seqirus Key News & Latest Developments
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Company Summary
7.6.2 Merck Sharp & Dohme Corp Business Overview
7.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Merck Sharp & Dohme Corp Key News & Latest Developments
7.7 Astellas Pharma US
7.7.1 Astellas Pharma US Company Summary
7.7.2 Astellas Pharma US Business Overview
7.7.3 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.7.4 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma US Key News & Latest Developments
7.8 Pfizer Inc
7.8.1 Pfizer Inc Company Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Inc Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Summary
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business Overview
7.11.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.11.4 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Company Summary
7.12.2 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business Overview
7.12.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.12.4 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Emergent BioSolutions Inc Key News & Latest Developments
8 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity, Analysis
8.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity, 2018-2030
8.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Supply Chain Analysis
10.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Value Chain
10.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Upstream Market
10.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in Global Market
Table 2. Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Companies, (K Doses), 2018-2023
Table 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table 9. List of Global Tier 1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2018-2023
Table 15. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2024-2030
Table 16. By Application ? Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2018-2023
Table 20. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2024-2030
Table 21. By Region ? Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2018-2023
Table 25. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2024-2030
Table 26. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2018-2023
Table 29. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2024-2030
Table 30. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2024-2030
Table 34. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2024-2030
Table 38. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2018-2023
Table 41. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2024-2030
Table 42. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2024-2030
Table 46. Sanofi Pasteur Company Summary
Table 47. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 48. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Sanofi Pasteur Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 52. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Protein Sciences Corporation Company Summary
Table 55. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 56. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Protein Sciences Corporation Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 60. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Seqirus Company Summary
Table 63. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 64. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Seqirus Key News & Latest Developments
Table 66. Merck Sharp & Dohme Corp Company Summary
Table 67. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 68. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Merck Sharp & Dohme Corp Key News & Latest Developments
Table 70. Astellas Pharma US Company Summary
Table 71. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 72. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Astellas Pharma US Key News & Latest Developments
Table 74. Pfizer Inc Company Summary
Table 75. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 76. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Pfizer Inc Key News & Latest Developments
Table 78. Johnson & Johnson Company Summary
Table 79. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 80. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Johnson & Johnson Key News & Latest Developments
Table 82. Lanzhou Institute of Biological Products Co., Ltd Company Summary
Table 83. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 84. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Lanzhou Institute of Biological Products Co., Ltd Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 88. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Emergent BioSolutions Inc Company Summary
Table 91. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 92. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. Emergent BioSolutions Inc Key News & Latest Developments
Table 94. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 95. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region, 2018-2023 (K Doses)
Table 97. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region, 2024-2030 (K Doses)
Table 98. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Opportunities & Trends in Global Market
Table 99. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Drivers in Global Market
Table 100. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Restraints in Global Market
Table 101. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials
Table 102. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials Suppliers in Global Market
Table 103. Typical Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream
Table 104. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream Clients in Global Market
Table 105. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type in 2022
Figure 2. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Application in 2022
Figure 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales in Global Market: 2018-2030 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue in 2022
Figure 9. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose), 2018-2030
Figure 13. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose), 2018-2030
Figure 17. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 23. US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 37. China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity (K Doses), 2018-2030
Figure 53. The Percentage of Production Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Region, 2022 VS 2030
Figure 54. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
